NAT Screening in Blood Donations
Keywords:
-Abstract
-
Downloads
References
Sheran LA Impact of nucieic acid testing for human immuno deficiency virus and hepatitis C virus on blood product avaiability, outdating, and patient safety. Arch Pathol Lab Med 2002:126:1463-6.
Dr.Holland PV. University of California at Davis Medical School/Center, USA., Personal communication.
Dodd RY, Notari IV EP, Stramer SL. Current prevalence and incidence of intections disease markers and estimated window - period risk in the Amerioan Red Cross Blood Donor Population. Transtusion 2002:2:975-9.
Schreiber GB, Busch MP, Kleinman SH, Kovelite JJ. The risk of transtusion- n-transmitted viral infections. The Retrovirus Epideriology Donor Study. N Engl J Med 1996;334:1685-90.
Dodd RY, Aberle-Grasse JM, Stramer SL. ARCNET Program. The Yield of nucleio acid testing (NAT) for HIV and HCV RNA in a population of US voluntary donors:relationship to contemporary measures of incidence (abstract). Transfusion 2000;40(Supple):1S.
Alvarez M, Oyonarte S, Rodriguez PM, Hemandez JM. Estimated risk of transfusion-transmitted viral intections in Spain. Transfusion 2002:42:994-8.
Seifriel E, Roth WK. Feasibility, Efficacy and Economy of NAT Testing in Germany, Blood Banking and Transfusion Medicine Journal of Blood Banks and Transfusion Society of Turkey, Vol. 1, No 1, July 2003 Supplement 1, S 27-28.
Mine H, Emura H, Miyamoto M, et al. High throughout screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodefciency virus type -1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Journal of Virological Methods 2003;112:145-51.
Meng Q, Wong C, Rangachari A, et al. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type-1 RNA. J Clin Microbiol. 2001:39:2937-45.
Japanese Red Cross NAT Screening Research group, Menegeshi K, Yoshikawa. A, Shinya K, et al. Superiority of minipool NAT for HBV over chemiluminescence immunoassay (CLIA) for HBsAg screening with over
million NAT routine screening in Japan. Vox Sanguinis 2003:84:287-91.
Dr. Juji T, Japanese Red Cross Blood Center, Tokyo Japan, Personnal communication.
Dr. Dax E, National Reference Laboratory, Australia (NRL), Personnal communication.
Coghlan J Patrick, The global and Australian Experience of NAT Application, Scientific meeting at National Blood Center, Thai Red Cross Society, Bangkok, 18 Jan. 2004.
Ghiazza P, Chiara M, Demarin G, et al. Sensitivity in NAT screening for Blood Units : A particular sample found in Blood Service in Turin (Abstract P.277). Journal of Blood Banks and Transfusion Society of Turkey Vol. 1 No.1 July 2003: Supplement 1. S 374.
Marchiori G, Gessoni G, Borin P, et al. HCV-RNA screening in a medium size Italian Transfusionale Service : Three years of experience, (abstract P.289) Journal of Blood Banks and Transfusion Society of Turkey Vol 1. No.1 July 2003: Supplement 1. S.377.
Marchiori G, Barin P, Frigato A, et al. HIV-RNA screening in median size Italian Transfusional Service (abstract P.290) 19 months of experience. Journal of Blood Banks and Transfusion Society of Turkey Vol. 1, No 1, July 2003: Supplement 1, S 374.
Grabarczyk P, Brojer E, et al. Validation of the Procleix HIV-1/HCV Assay in Poland (abstract P280). Joumal of Blood Banks and Transfusion Society of Turkey Vol.1 No.1 July 2003:Supplement 1. S. 374.
ศรีวิไล ตันประเสริฐ. Nucleic Acid Technique Screening มีความเป็นไปได้อย่างไร. วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต 2544:11;173-7.
รัชนี โอเจริญ. NAT for Addition Markers: Implication for Blood Safety วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต 2547:14;289-93.
Pillonel J, Laperche S, Saura C, et al. Trends in residual risk of transfusion transmitted viral infections in France between 1992 and 2000, Transfusion 2002;42:980-8.
Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV and HBV in whole blood donations. Transtusion 2003:43:721-9.
AuBuchon JP, Bukmyer JD, Busch MP. Safety of the blood supply in the United States : Opportunities and controversuses. Ann Intern Med 1997:127:904-9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
